Neurocrine Biosciences
NBIX
#1611
Rank
โ‚น874.21 B
Marketcap
โ‚น8,768
Share price
-5.01%
Change (1 day)
-23.63%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Neurocrine Biosciences (NBIX) - Net assets

Net assets on the balance sheet as of December 2024 : โ‚น220.71 Billion

According to Neurocrine Biosciences 's latest financial reports the company has โ‚น220.71 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Neurocrine Biosciences - Net assets on balance sheet (from 2001 to 2024)

Net assets by year

Year Net assets Change
2024-12-31$โ‚น222.16 B19.56%
2023-12-31$โ‚น185.81 B31.48%
2022-12-31$โ‚น141.32 B38.19%
2021-12-31$โ‚น102.26 B24.17%
2020-12-31$โ‚น82.36 B81.35%
2019-12-31$โ‚น45.41 B35.11%
2018-12-31$โ‚น33.61 B41.47%
2017-12-31$โ‚น23.76 B11.05%
2016-12-31$โ‚น21.39 B-24.14%
2015-12-31$โ‚น28.20 B113.26%
2014-12-31$โ‚น13.22 B77.81%
2013-12-31$โ‚น7.43 B-11.99%
2012-12-31$โ‚น8.45 B165.94%
2011-12-31$โ‚น3.17 B266.65%
2010-12-31$โ‚น0.86 B372.49%
2009-12-31$โ‚น0.18 B-89.62%
2008-12-31$โ‚น1.76 B-62.06%
2007-12-31$โ‚น4.65 B-66.58%
2006-12-31$โ‚น13.93 B-20.6%
2005-12-31$โ‚น17.55 B2.92%
2004-12-31$โ‚น17.05 B-4.22%
2003-12-31$โ‚น17.80 B65.59%
2002-12-31$โ‚น10.75 B-28.2%
2001-12-31$โ‚น14.97 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
โ‚น168.12 B-23.82%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น881.45 B 299.37%๐Ÿ‡ฌ๐Ÿ‡ง UK
-โ‚น0.55 Billion-100.25%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น1.216 T 451.09%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น286.70 B 29.90%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น7.542 T 3,317.27%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น36.52 B-83.45%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น3.11 Billion-101.41%๐Ÿ‡บ๐Ÿ‡ธ USA